Researcher Eva Rohde and her team awarded with distinction

8. November 2021

Philip Levine Research Award for Salzburg team

Eva Rohde and her team at Paracelsus Medical University are being awarded the Philip Levine Prize by the German Society for Transfusion Medicine and Immunohematology for their outstanding scientific work.

Great hopes are being placed worldwide in research with extracellular vesicles, which is considered one of the most important cell therapies of the future. The Good Manufacturing Practice Laboratory, abbreviated as GMP Laboratory Salzburg, is among the few academic-pharmaceutical institutions worldwide that can produce vesicles for administration to humans.

International institutions such as the biotech company Paracrine Therapeutics from Singapore collaborate with this centerpiece of the Center for Cross-Sectional and Tissue Regeneration. Salzburg plays an outstanding role in terms of equipment, expertise, and quality.

Vesicles – more than just “garbage”

Extracellular vesicles, long dismissed as the “garbage system” of cells, have an important communication function in the body: they transmit targeted information between cells, organs, and even between different organisms. Vesicles have potential as gatekeeper systems. Their role is particularly promising in regenerative medicine.

“It’s like two soap bubbles merging with each other,” explains Rohde. “The information thus reaches the target cell.” Research groups from Essen, Hannover, and Salzburg, in addition to the GMP laboratory, play an important role. New therapeutics based on vesicles are being developed in a cleanroom environment.

A significant advantage of these tiny powerhouses is their volume, which is at a ratio of 1:3,000,000 compared to the cell. They have the ability to suppress inflammatory processes and reduce scar formation. This tremendous potential could be an important key, for example, in the healing of hearing implants in the inner ear.

You might also be interested in

17. January 2024

Research premium – this is how you apply!

SMEs can apply to the tax office for a research premium for expenditure on research and development (R&D). We show you how it works!

13. October 2023

Circular Economy:
Building with and in Existing Structures

“Dismantle. Breakthrough. Departure.” was the motto of this year’s Alpine Construction Symposium at the Salzburg University of Applied Sciences on October 12, 2023. The focus was on topics related to construction in existing structures and the recycling of materials from decommissioned buildings. There are many challenges in this regard, but also solutions.

18. September 2023

At the Interface Between Human and Computer: The New III.Lab in Salzburg

The triple I in the lab name stands for “Intelligent Interfaces Innovation,” describing research at the intersection of humans and technologies. The lab was inaugurated on September 15, 2023, and is available for collaborations with companies, emphasizing planned application-oriented research.

19. July 2023

From Mozart to Hightech

In the Austria Picture that aired on ORF 2 on June 11th, our CEO Walter Haas stated, “Salzburg should stand for research, technology, and the future.” The program, produced by the Salzburg Regional Studio, focused on our innovation ecosystem.

Our Newsletter